Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.217121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Jingjing Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Retinoblastoma, Retinoblastoma Binding Proteins, Retinal Neoplasms, DNA Methylation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research.
Abstract (Originalsprache)
Retinoblastoma (RB) is the most common intraocular malignancy in childhood. The causal variants in RB are mostly characterized by previously used short-read sequencing (SRS) analysis, which has technical limitations in identifying structural variants (SVs) and phasing information. Long-read sequencing (LRS) technology has advantages over SRS in detecting SVs, phased genetic variants, and methylation. In this study, we comprehensively characterized the genetic landscape of RB using combinatorial LRS and SRS of 16 RB tumors and 16 matched blood samples. We detected a total of 232 somatic SVs, with an average of 14.5 SVs per sample across the whole genome in our cohort. We identified 20 distinct pathogenic variants disrupting RB1 gene, including three novel small variants and five somatic SVs. We found more somatic SVs were detected from LRS than SRS (140 vs. 122) in RB samples with WGS data, particularly the insertions (18 vs. 1). Furthermore, our analysis shows that, with the exception of one sample who lacked the methylation data, all samples presented biallelic inactivation of RB1 in various forms, including two cases with the biallelic hypermethylated promoter and four cases with compound heterozygous mutations which were missing in SRS analysis. By inferring relative timing of somatic events, we reveal the genetic progression that RB1 disruption early and followed by copy number changes, including amplifications of Chr2p and deletions of Chr16q, during RB tumorigenesis. Altogether, we characterize the comprehensive genetic landscape of RB, providing novel insights into the genetic alterations and mechanisms contributing to RB initiation and development. Our work also establishes a framework to analyze genomic landscape of cancers based on LRS data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. Electronic address: yanghs64@126.com.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. Electronic address: wuzhikun86@163.com.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China. Electronic address: xiezhi@gmail.com.
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
Zitieren
APA
Zheng, J., Li, T., Ye, H., Jiang, Z., Jiang, W., Yang, H., Wu, Z., & Xie, Z. (2024). Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217121
Vancouver
Zheng J, Li T, Ye H, Jiang Z, Jiang W, Yang H, et al. Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.217121
BibTeX
@article{Zheng2024,
author = {Zheng, Jingjing and Li, Tong and Ye, Huijing and Jiang, Zehang and Jiang, Wenbing and Yang, Huasheng and Wu, Zhikun and Xie, Zhi},
title = {Comprehensive identification of pathogenic variants in retinoblastoma by long- and short-read sequencing},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.217121}
}
EUVIMED